Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based Approach
CUPID
1 other identifier
interventional
1,424
1 country
1
Brief Summary
This research will evaluate the effectiveness and implementation of a couples shared decision-making intervention, CUPID (Couples United in HIV Prevention Informed Decisions), delivered in community and clinic settings to support women's pre-exposure prophylaxis (PrEP) choice and use through male partner support and shared decision-making. Through a partnership with Ministry of Health clinics already providing choices for PrEP in Uganda, the investigators will evaluate whether CUPID is effective in increasing PrEP uptake, persistence, and use among Ugandan women and assess implementation outcomes to determine whether it is acceptable and feasible to implement. If successful, CUPID will offer a community-based strategy for engaging male partners to support PrEP choice and improve HIV prevention among women and provide a scalable and sustainable intervention that will contribute to a more comprehensive approach to HIV prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable hiv
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2026
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 8, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2028
May 8, 2026
May 1, 2026
1.8 years
April 27, 2026
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PrEP persistence
Number of PrEP refill/administration visits by women per week: 2nd refill visits for oral PrEP, PrEP ring and injectable cabotegravir (\~3 month persistence); 1st refill (at 6 months) for injectable lenacapavir
Weekly for 48 weeks
Secondary Outcomes (3)
PrEP uptake
Weekly for 64 weeks
6-month PrEP persistence
Weekly for 36 weeks
PrEP use: Objective adherence
Weekly for 48 weeks
Study Arms (1)
CUPID shared decision-making counseling intervention
EXPERIMENTALInterventions
The CUPID shared decision-making counseling intervention involves delivery of a paper-based, shared decision-making tool in community and clinic settings by PrEP delivery staff and Community Health Teams affiliated with each health facility. The intervention is designed as a single session in which a couple will go through the decision tool, guided by a trained member of a Community Health Team (which can include Community Health Extension Workers, Peer Educators, PrEP Ambassadors, Village Health Teams, or other personnel affiliated with MOH clinics trained to operate in communities), with onsite support, as needed, from a PrEP delivery staff, counselors, or other health providers. The CUPID shared decision-making model provides a patient-centered approach to encourage an informed and active role in decision making by providing couples with knowledge about the available options and helping to clarify their needs and values relevant to the decision.
Eligibility Criteria
You may qualify if:
- All Aims:
- Able and willing to provide written informed consent
- Fluent in English or the dominant language spoken in the health facility's region.
- Aim 1:
- Age ≥18 years
- Meets one of the following criteria:
- Performs tasks related to PrEP outreach and/or delivery in former CATALYST study areas. This may include clinic and non-clinic positions.
- Is a member of one of the three regional CATALYST CABs
- Willing to participate in a focus group discussion
- Aim 2:
- Aged 18 years or older
- Attending a PrEP follow-up visit
- Able and willing to complete all study procedures.
- Aim 3:
- Age ≥18 years
- +6 more criteria
You may not qualify if:
- All Aims: Participants will be excluded who have any condition that, in the opinion of the MPI or designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
- Aim 2:
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RTI Internationallead
- National Institute of Mental Health (NIMH)collaborator
- MU-JHU CAREcollaborator
- University of Washingtoncollaborator
Study Sites (1)
Makerere University-Johns Hopkins University Research Collaboration
Kampala, Uganda
Study Officials
- PRINCIPAL INVESTIGATOR
Brenda Gati Mirembe, MBChB, MSc
Makerere University-Johns Hopkins Research Collaboration /MU-JHU CARE LTD
- PRINCIPAL INVESTIGATOR
Carolyne A Akello, MBChB, MSc
MU-JHU Research Collaboration/ Ministry of Health
- PRINCIPAL INVESTIGATOR
Alexandra M Minnis, PhD, MPH
RTI International
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator; Director, Public Health
Study Record Dates
First Submitted
April 27, 2026
First Posted
May 8, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
March 1, 2028
Study Completion (Estimated)
March 1, 2028
Last Updated
May 8, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ICF
- Time Frame
- IPD will be uploaded to the NIMH Data Archive twice per year and will be made publicly available at the end of the study period.
- Access Criteria
- Researchers will access to the NIMH Data Archive will be able to access the IPD and supporting information provided.
Data and data dictionaries will be shared through the NIMH Data Archive.